Next Article in Journal
A Novel Step-T-Junction Microchannel for the Cell Encapsulation in Monodisperse Alginate-Gelatin Microspheres of Varying Mechanical Properties at High Throughput
Next Article in Special Issue
Rapid Detection of Attomolar SARS-CoV-2 Nucleic Acids in All-Dielectric Metasurface Biosensors
Previous Article in Journal
A Novel Methodology for Detecting Variations in Cell Surface Antigens Using Cell-Tearing by Optical Tweezers
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot

1
College of Mechanical and Electronic Engineering, Dalian Minzu University, Dalian 116600, China
2
CAS Key Laboratory of Separation Science for Analytical Chemistry, Dalian Institute of Chemical Physics, Chinese Academy of Sciences, 457 Zhongshan Road, Dalian 116023, China
3
University of the Chinese Academy of Sciences, Beijing 100049, China
*
Authors to whom correspondence should be addressed.
Biosensors 2022, 12(8), 658; https://doi.org/10.3390/bios12080658
Submission received: 20 July 2022 / Revised: 16 August 2022 / Accepted: 17 August 2022 / Published: 19 August 2022

Abstract

:
Rapid and sensitive detection of cancer biomarkers is crucial for cancer screening, early detection, and improving patient survival rate. The present study proposes an electrochemical gene-sensor capable of detecting tumor related TP53 gene mutation hotspots by self-assembly of sulfhydryl ended hairpin DNA probes tagged with methylene blue (MB) onto a gold electrode. By performing a hybridization reaction with the target DNA sequence, the gene-sensor can rearrange the probe’s structure, resulting in significant electrochemical signal differences by differential pulse voltammetry. When the DNA biosensor is hybridized with 1 μM target DNA, the peak current response signal can decrease more than 60%, displaying high sensitivity and specificity for the TP53 gene. The biosensor achieved rapid and sensitive detection of the TP53 gene with a detection limit of 10 nmol L−1, and showed good specific recognition ability for single nucleotide polymorphism (SNP) and base sequence mismatches in the TP53 gene affecting residue 248 of the P53 protein. Moreover, the biosensor demonstrated good reproducibility, repeatability, operational stability, and anti-interference ability for target DNA molecule in the complex system of 50% fetal bovine serum. The proposed biosensor provides a powerful tool for the sensitive and specific detection of TP53 gene mutation hotspot sequences and could be used in clinical samples for early diagnosis and detection of cancer.

1. Introduction

Despite advancements in medical care, cancer continues to be the most common cause of death. The key to cancer treatment lies in early detection, diagnosis, and treatment [1]. Currently, early detection of cancer is accomplished by the use of blood chip detection [2], gene detection [3], nano detection [4], positron emission tomography (PET) [5], computed tomography (CT) [6], and other approaches [7]. However, these approaches are highly limited in terms of early cancer detection due to their low sensitivity, high cost, and potential for physical or chemical harm [8]. Additionally, while enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR)-based technologies have high sensitivity and are less invasive, they require long detection times and involve high costs for operation [9,10,11]. As a result, creating analytical tools for the early detection of cancer is critical for medical diagnosis.
TP53 is a gene that acts as a tumor suppressor. This gene is mutated in more than 50% of all cancers [12,13] such as liver cancer [14], breast cancer [15], esophageal cancer [16], and lung cancer [17]. The majority of TP53 mutations in human tumors occur in the highly conserved region, with the highest mutation rates occurring at R175, R248, R249, R273, and R282 [18]. Due to its altered spatial conformation, TP53 loses its ability to regulate cell growth, apoptosis, and DNA repair, and ultimately transitions from a tumor suppressor to an oncogene [19]. As a result of the close association between the TP53 gene and cancer, conditions for early detection of cancer are created.
Over the last two decades, the importance of precise early illness detection and the development of personalized therapy have grown. In order to further improve the sensitivity and specificity of cancer marker detection, several novel analytical strategies such as electrochemical methods and electrochemiluminescence methods have been developed [20,21]. Thanks to its short detection time, distinctive hybridization specificity, and miniaturization potential, DNA-based electrochemical biosensors have attracted broad scientific and clinical interest recently [22]. Using electrochemical DNA biosensors based on the hybridization of DNA, specific target sequences can be subsequently measured, wherein a complementary capture probe recognizes the target DNA sequence [23]. The mass of the single-stranded DNA probe monolayer represents a major concern for building sensitive electrochemical biosensors, since the accessibility of target molecules is determined by the homogeneity, density, and upright conformation of ssDNA probes on the electrode surface [24,25]. The signal amplifier, the second component, converts minor changes in the interface into a detectable electrochemical signal [26]. Electrochemical DNA sensors have improved their detection performance when the single-stranded capture probe undergoes structural change from coiled to double-stranded DNA [23,27]. Concurrently, electrochemical DNA sensors provide improved selectivity for identifying tumor-related key genetic indicators such as single nucleotide polymorphism (SNP). The relatively poor selectivity of linear DNA probes for SNP is a typical problem in mutation analysis since the difference in melting temperatures between totally matched and SNP-containing hybrids can be as tiny as 1–2 °C [28]. If the mutation occurs within the loop area, the molecular beacon technique enhances this difference, resulting in greater discrimination between intact and mutant sequences [29]. Therefore, early diagnosis of patients with sensitive and accurate electrochemical gene-sensors may significantly improve patient survival rates [30,31]. Although TP53 gene mutation detection plays an important role in the early diagnosis of cancer, related electrochemical sensors have rarely been reported.
In this study, we constructed a simple and reliable gene-sensor based on an electronic DNA hairpin molecular beacon. Using the high-frequency mutation site R248 of the TP53 gene and its association with cancer, a hairpin probe was functionalized by modification of sulfhydryl and methylene blue (MB). The DNA biosensor with high sensitivity for SNP was designed to be able to effectively distinguish between intact, SNP-containing cancer biomarkers and three-base mismatch sequences, which is of great importance in early cancer screening.

2. Experimental Section

2.1. Chemicals and Reagents

6-Mercapto-1-hexanol (MCH) was obtained from J&K Chemical Ltd. (Beijing, China). Sodium chloride (NaCl), sulfuric acid (H2SO4), potassium dihydrogen phosphate (KH2PO4), dibasic sodium phosphate (Na2HPO4), potassium hexacyanoferrate (III) (K3Fe(CN)6), and potassium hexacyanoferrate (II) trihydrate (K4Fe(CN)6·3H2O) were obtained from Sigma (St. Louis, MO, USA). A Milli-Q purification system (Millipore, Burlington, MA, USA) with a resistivity of 18 MΩ·cm was used to obtain ultrapure water. Tris (2-carboxyethyl) phosphine hydrochloride (TCEP), tris-EDTA buffer solution (TE buffer) and the oligonucleotide sequences (Table S1 in supporting information) were synthesized by Sangon Biotech (Shanghai, China) Co., Ltd.

2.2. Preparation and Immobilization of DNA Sensors

Polycrystalline gold electrodes (2 mm diameter) were used to immobilize the SL-DNA probe. Polycrystalline gold electrodes were washed in a piranha solution (H2O2:H2SO4 = 1:3, v/v) for 15 min before being polished with 1.0, 0.3, and 0.05 m alumina slurry. Following rinsing, the electrodes were cleaned ultrasonically three times with ethanol followed by Milli-Q water. They were then electrochemically activated in 0.5 mol L−1 H2SO4 by potential scanning between 0 and 1.7 V until a repeatable CV was achieved, after which they were thoroughly washed with Milli-Q water and dried under a nitrogen stream [32,33].
A gold-thiol bond was used to secure the ssDNA probe to the electrode surface. The disulfide bonds of the ssDNA probe were reduced with 10 mM TCEP by vibrating the solution at room temperature for 1 h. Following this, the solution was further diluted to obtain 0.01 μM, 0.1 μM, 1 μM, and 10 μM of the DNA probe in pH 7.4 phosphate-buffered saline (PBS). A total of 5 µL of this solution was drop cast onto the electrode and incubated at 4 °C for 16 h. The electrodes were submerged in PBS for 15 min and then dried with nitrogen stream. To avoid unintended adsorption on the electrode surface, the electrodes were dipped in 15 mL of 2 mM MCH in PBS and incubated for 1 h. Subsequently, the electrodes were immersed in PBS for 15 min and dried with nitrogen to obtain ssDNA-Au electrode (i.e., the geno-sensor). At the beginning of the hybridization reaction, 5 µL PBS solution containing cDNA were placed onto the ssDNA-Au electrodes and allowed to react at room temperature for 30 min. Subsequently, the electrodes were immersed in PBS for 15 min and dried with nitrogen to yield dsDNA-Au. The fabrication procedures for the biosensor are schematically depicted in Figure 1.

2.3. Electrochemical Measurements and Procedure

Cyclic voltammetry (CV), differential pulse voltammetry (DPV), and electrochemical impedance spectroscopy (EIS) experiments were performed in a three-electrode cell made of glass using a portable potentiostat, PalmSens4 (PalmSens4, Houten, The Netherlands) equipped with PS Trace 5.8 software (5.8.1704.0, PlamSens BV, Houten, The Netherlands). The prepared DNA sensor as the working electrode, an Ag/AgCl (3 M KCl) as the reference electrode, and a platinum wire as the auxiliary electrode. The assembly and hybridization reactions of the produced ssDNA-Au or dsDNA-Au were monitored using electrochemical scanning in PBS or [Fe(CN)6]3−/4− solution. CV and DPV were performed on ssDNA-Au or dsDNA-Au from −0.5 to 0 V at a scan rate of 50 mV s−1 in PBS. In DPV, a pulse amplitude of 50 mV, a potential increment of 1 mV and a pulse width of 16.7 ms were employed. EIS spectra of the DNA sensors were recorded in a solution consisting of K3Fe(CN)6/K4Fe(CN)6 (0.005M) and 0.1 M KCl at a frequency range from 105 Hz to 0.1 Hz.
The electrochemical method was used to determine the effective surface area (Aeff) of working electrodes using K3[Fe(CN)6] as a probe [34]. CV of 5 mM K3[Fe(CN)6] in 0.1 M KCl at bare electrode was obtained at 50 mVs−1 scan rate. The effective surface areas of gold electrodes were calculated according to the previously reported method [35].
The DNA surface coverage ( Γ , pmol/cm2) was calculated using Equation (1).
Γ = Q n F A e f f
where Q (C), n, F, and Aeff represent the reduced charge of an electrochemical indicator (MB) in cyclic voltammetry obtained for the ssDNA-Au electrodes, the quantity of electrons involved in the reaction (2e), the Faraday constant (96,485 × 10−12 C/pmol), and the effective area of the Au disk electrode, respectively [36,37]. The DNA surface coverage was determined by integrating the second scan’s reduction peak of cyclic voltammograms.

3. Results and Discussion

3.1. Design of the DNA Beacon Sequences

The hairpin beacons were designed using the DNA sequence of one of the most investigated genes in cancer research, the TP53 gene. A 28 nt hairpin DNA strand with a stem and a loop was designed to complement the TP53 biomarker. The complementation sequence detection of the arginine-tryptophan mutation sequence was designed using a single nucleotide polymorphism and the triple base mismatch (TBM) sequence. The detection of single base mismatch (SBM) with a mutation (G to A) at residue R248 enables sensitive recognition to frequently occurring cancer-causing mutations.

3.2. Characterization of the Self-Assembled DNA Sensor

The DNA beacons were mounted on gold electrodes and electrochemically characterized in their folded and open states (i.e., prior to and following hybridization with the target DNA). Biosensor fabrication and EIS measurements were characterized using 0.1 M KCl containing 5 mM K3Fe(CN)6 and K4Fe(CN)6. As shown in Figure 2, the semicircle at a high frequency in EIS, represents the charge transfer process, and its diameter represents the charge transfer impedance (Rct) value. The low-frequency linear part represents the electron transfer process of mass diffusion control [38,39]. In comparison to the bare Au electrode (curve a), the ssDNA-Au electrode demonstrated a significantly higher electron-transfer resistance Rct (curve b), owing to the negatively charged phosphate backbone of the ssDNA bound on the electrode’s surface. It will repel [Fe(CN)6]3−/4−, which also have negative charges. Electron transfer is limited by increased steric hindrance and charge accumulation on the electrode surface [40], resulting in a considerable increase in Rct. Subsequent surface blocking with MCH led to a further increase of Rct (curve c), indicating the successful preparation of an electrochemical biosensor. After hybridization of the biosensor with the target cDNA, dsDNA can be formed. On the electrode surface, a huge amount of negatively charged DNA can be accumulated to block electron transmission, resulting in a significantly increased Rct (curve d).

3.3. Electron Transfer Dynamics Study in MB-Labeled Electrodes

CV was used to determine the dynamics of the response in ssDNA-Au and dsDNA-Au with a scan rate range of 5 to 600 mV s−1. In Figure 3A, the peak currents of the anodic and cathodic gradually increase as the scan rates increase. The peak currents are clearly proportional to the square root of the scanning rates (Figure 3A). Upon hybridization, despite the fact that MB is far from the electrode surface due to the rigid structure of the double-stranded DNA, resulting in a low electron transfer (ET) rate and reduced current, the peak currents still have a clear linear relationship with the square root of the scan rates (Figure 3B). They are indicative of a surface-controlled electron transfer process on the electrode’s surface [39,41,42]. Compared to the dsDNA-Au electrode, a more rapid electron transfer rate and larger response current are demonstrated on the ssDNA-Au electrode.

3.4. The Feasibility of the DNA Sensor

We used DPV to examine the feasibility of the DNA sensor (Figure 4). A well-defined peak of MB was found at −0.25 V when the electrode was coated with ssDNA tagged MB. The oxidation peak of MB rose noticeably when the end-sealing agent MCH was immobilized on the electrode surface. The reason for this is that under the action of MCH, ssDNA that was previously distributed irregularly on the electrode surface can be fixed on the electrode with an upright structure, decreasing the distance between MB and the electrode (Figure 1). The distance between MB and the gold electrode increased after hybridization with target cDNA for 30 min, resulting in a significant decrease in peak current.

3.5. Analysis of Impact Factors

By comparing the changes in peak currents measured by CV and DPV, the effect of probe and cDNA concentration on sensor measurement can be determined. The probe concentration, as shown in Figure S1A, is a significant factor that influences sensor performance. 5 µL aliquots of ssDNA solutions at concentrations of 0.01, 0.1, 1, and 10 µM were fixed on the treated gold electrode’s for 16 h at 4 °C and then immersed in MCH for 1 h. Coverages of 0, 2.9, 11.55, and 9.57 pmol/cm2 were calculated, respectively (Equation (1)). The maximum theoretical surface coverage (30–45 pmol/cm2) is noticeably higher than the reported values for the DNA monolayer [43,44]. Figure S1B shows the probe coverage on the electrode rose first and then decreased, which is in agreement with the change of CV peak current. We applied 1 μM ssDNA for the next studies to maximize the coverage of ssDNA considering the cost of labelled DNA.
The signal changes were studied by hybridization with different concentrations of 21 nt cDNA sequences at the constant probe concentration of 1 μM for 30 min (Figure 5a). The concentrations of 21 nt cDNA were 10 nM, 50 nM, 100 nM, 500 nM, and 1 μM, respectively, and the percentage of peak current decrease in DPV demonstrated a good linear relationship with the logarithm of cDNA concentration (Figure 5b). The detection limit of the electrochemical DNA sensor was up to 10 nM due to the hairpin structure and signal amplification of MB. The obtained detection limit for TP53 is significantly better than that of the field-effect transistor sensor (100 nM) [45], and is comparable to that of the electrochemical biosensor developed by Otero et al. [37]. With an increase in cDNA concentration, the binding efficiency of the double-stranded was improved, and a larger amount of MB was far away from the electrode surface, resulting in a significant decrease in peak current. When the concentration was increased to 1 μM, the percentage of peak current reduction for 21nt-cDNA reached 60%, providing an ideal signal difference for cDNA detection. As can be seen, the DNA sensor showed high specificity and sensitivity for complementary TP53 gene detection. In order to further explore the effect of cDNA sequence length on response signal, the gene sensor was hybridized with 28nt-cDNA under the same conditions. As shown in Figure S2, the percentage of geno-sensor peak current reduction for 21nt-cDNA was much higher than for 28nt-cDNA, which demonstrates that the designed geno-sensor is more sensitive for 21nt-cDNA. So, 21nt-cDNA is preferable for further study.

3.6. The Specificity of the DNA Sensor

To further investigate the specificity of the DNA sensor, the SBM and TBM sequences were hybridized with DNA sensors, respectively, as shown in Figure 5c. Compared with the peak current value before hybridization, the change rate of the peak current value Δ et = ( I B i o s e n s o r I d s D N A )   /   I B i o s e n s o r after hybridization with different hybridization sequences is shown in Figure 5d. When the ssDNA sensor hybridizing with 1 μM cDNA, the Δet value is 60.29 ± 1.48%. When the ssDNA sensor hybridizing with 1 μM TBM or SBM, the Δet values are 45.55 ± 1.60%, 32.14 ± 1.23%, respectively. As can be seen, the DNA sensor displayed an ideal signal difference for detecting single base mismatches (SNP) and three-base mismatches base sequences. The mutation site of the single-base mismatch sequence is the R248 mutation hotspot of the TP53 gene, and the peak current change percentage of the biosensor for cDNA and SBM is quite different. This demonstrates that the DNA sensor can be used for the early diagnosis or early warning of cancer related to the R248 mutation hotspot of TP53.

3.7. The Reproducibility, Repeatability and Stability of the DNA Sensor

The reproducibility, repeatability, and stability of the DNA sensor were studied by using the DPV technique. The results of 10 consecutive potential scans of the prepared five different biosensors are shown in Figure 6. The relative standard deviation (R.S.D.) of the same biosensor response to 1 μM cDNA for 10 successive measurements was within 1.3%, indicating good repeatability and operational stability. To evaluate the reproducibility between DNA sensors, five biosensors were prepared under the same conditions independently. The R.S.D. of the obtained five gene-sensors was within 2%, indicating good reproducibility for electrode batches.

3.8. Detection of Target Molecules in Complex Systems

Early diagnosis of cancer is usually achieved by detecting tumor markers present in tumor tissue, serum, and peripheral blood [46]. However, the serum is a complex mixture, including plasma proteins, peptides, fats, carbohydrates, hormones, and so on. These substances are likely to have a certain impact on the detection signal of biosensor. Due to the fact that 50% fetal bovine serum (FBS) contains similar components to human serum, we used it to verify the anti-interference ability of the developed electrochemical biosensor in the complex detection environment. 50% FBS was used to simulate a complex biological sample for the detection of target DNA molecules, and the detection result was shown in Figure S3. The co-existing FBS did not interfere with the detection of target DNA, and the gene-sensor can still effectively distinguish target molecules with single base mismatch, indicating that the sensor can selectively identify target molecules in complex systems, and could be applied to clinical sample detection.

4. Conclusions

In summary, an electrochemical geno-sensor based on hairpin-DNA was developed to detect the mutation hotspot sequence of the TP53 tumor suppressor gene. A highly ordered hairpin DNA monolayer was formed on the surface of the gold electrode by self-assembly method. With the hybridization reaction with the target sequence, the hairpin probe structure was induced to rearrange into linear DNA double chains, and TP53 gene detection at nanomolar concentration was realized. The results demonstrate that the peak current decrease percentage of the sensor has a good linear relationship with the logarithm of the target DNA concentration (R2 = 0.998) with a low detection limit of 10 nmol L−1. More importantly, the biosensor showed sensitive specific recognition ability for a single nucleotide polymorphism in the TP53 gene affecting residue 248 of the P53 protein. There are about 15% and 28% difference in the change rates of peak currents for SBM and TBM compared to cDNA. At the same time, the gene-sensor demonstrated good reproducibility and stability and excellent anti-interference ability for the target DNA molecule in the complex system of 50% fetal bovine serum. It is expected to be applied to the detection of clinical samples and provides a promising rapid method for the early diagnosis and early detection of cancer.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/bios12080658/s1, Table S1: The used oligonucleotides in this study; Figure S1: CV of a gold electrode after 16 h exposure to ssDNA at concentrations of 10 nM, 100 nM, 1 μM and 10 μM in pH 7.4 PBS (A), and electrode surface coverage of ssDNA probes with different concentrations (B); Figure S2: DPV curves of the electrochemical geno-sensor after 30 min hybridization to 1 μM 21 nt cDNA and 28 nt cDNA, respectively; Figure S3: Detection capabilities of the DNA sensors for target DNA in complex systems of 50% fetal bovine serum.

Author Contributions

Conceptualization, X.L. and H.D.; methodology, P.S.; validation, P.S., K.N. and R.L.; formal analysis, P.S. and K.N.; investigation, P.S. and K.N.; resources, X.L.; data curation, P.S.; writing—original draft preparation, P.S. and X.L.; writing—review and editing, X.L., H.D. and J.C.; visualization, P.S.; supervision, X.L. and H.D.; project administration, X.L.; funding acquisition, X.L.All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the National Natural Science Foundation of China (Grant No. 22076181), Dalian Science and Technology Innovation Fund (2020JJ26SN057), and DICP (Grant No. DICP I202001).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

The authors are grateful to the National Natural Science Foundation of China (Grant No. 22076181), Dalian Science and Technology Innovation Fund (2020JJ26SN057), and DICP (Grant No. DICP I202001) for the financial support.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. McPhail, S.; Johnson, S.; Greenberg, D.; Peake, M.; Rous, B. Stage at diagnosis and early mortality from cancer in England. Br. J. Cancer 2015, 112 (Suppl. S1), S108–S115. [Google Scholar] [CrossRef] [PubMed]
  2. Yu, Z.; Lin, S.; Xia, F.; Liu, Y.; Zhang, D.; Wang, F.; Wang, Y.; Li, Q.; Niu, J.; Cao, C.; et al. ExoSD chips for high-purity immunomagnetic separation and high-sensitivity detection of gastric cancer cell-derived exosomes. Biosens. Bioelectron. 2021, 194, 113594. [Google Scholar] [CrossRef] [PubMed]
  3. Sunidhi, C.R.; Jeyaprakash, M.R.; Rajeshkumar, R. Sonic Hedgehog gene as a potential target for the early prophylactic detection of cancer. Med. Hypotheses 2020, 137, 109534. [Google Scholar] [CrossRef]
  4. Altunkök, N.; Ünlüer, Ö.B.; Özkütük, E.B.; Ersöz, A. Development of potentıometrıc bıosensor for dıagnosıs of prostate cancer. Mater. Sci. Eng. B 2021, 263, 114789. [Google Scholar] [CrossRef]
  5. Gupta, M.; Choudhury, P.S.; Rawal, S.; Singh, A. Oligometastasis to testis in prostate cancer: Role of gallium-68 prostate-specific membrane antigen positron-emission tomography computed tomography. World J. Nucl. Med. 2021, 20, 113–116. [Google Scholar] [CrossRef] [PubMed]
  6. Farooq, M.; Herman, J.G. Noninvasive Diagnostics for Early Detection of Lung Cancer: Challenges and Potential with a Focus on Changes in DNA Methylation. Cancer Epidemiol. Biomark. Prev. 2020, 29, 2416–2422. [Google Scholar] [CrossRef] [PubMed]
  7. Yang, G.; Xiao, Z.; Tang, C.; Deng, Y.; Huang, H.; He, Z. Recent advances in biosensor for detection of lung cancer biomarkers. Biosens. Bioelectron. 2019, 141, 111416. [Google Scholar] [CrossRef]
  8. Wang, L. Screening and Biosensor-Based Approaches for Lung Cancer Detection. Sensors 2017, 17, 2420. [Google Scholar] [CrossRef]
  9. de Melo-Silva, A.J.; Lucena, J.P.; Hueneburg, T. The evolution of molecular diagnosis using digital polymerase chain reaction to detect cancer via cell-free DNA and circulating tumor cells. Cell Biol. Int. 2020, 44, 735–743. [Google Scholar] [CrossRef]
  10. Ito, E.; Iha, K.; Yoshimura, T.; Nakaishi, K.; Watabe, S. Early diagnosis with ultrasensitive ELISA. Adv. Clin. Chem. 2021, 101, 121–133. [Google Scholar]
  11. Rusling, J.F.; Kumar, C.V.; Gutkind, J.S.; Patel, V. Measurement of biomarker proteins for point-of-care early detection and monitoring of cancer. Analyst 2010, 135, 2496–2511. [Google Scholar] [CrossRef] [PubMed]
  12. Baugh, E.H.; Ke, H.; Levine, A.J.; Bonneau, R.A.; Chan, C.S. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 2018, 25, 154–160. [Google Scholar] [CrossRef] [PubMed]
  13. Bidar, N.; Amini, M.; Oroojalian, F.; Baradaran, B.; Hosseini, S.S.; Shahbazi, M.-A.; Hashemzaei, M.; Mokhtarzadeh, A.; Hamblin, M.R.; de la Guardia, M. Molecular beacon strategies for sensing purpose. TrAC Trends Anal. Chem. 2021, 134, 116143. [Google Scholar] [CrossRef]
  14. Kato, T.; Murata, D.; Anders, R.A.; Sesaki, H.; Iijima, M. Nuclear PTEN and p53 suppress stress-induced liver cancer through distinct mechanisms. Biochem. Biophys. Res. Commun. 2021, 549, 83–90. [Google Scholar] [CrossRef]
  15. Rana, M.K.; Rana, A.P.S.; Khera, U. Expression of p53 and p16 in Carcinoma Breast Tissue: Depicts Prognostic Significance or Coincidence. Cureus 2021, 13, e19395. [Google Scholar] [CrossRef]
  16. Suzuki, L.; Nieboer, D.; van Lanschot, J.J.B.; Spaander, M.C.W.; Looijenga, L.H.J.; Biermann, K. Effect of neoadjuvant chemoradiotherapy on p53 and SOX2 protein expression in esophageal adenocarcinoma. Biomark. Med. 2020, 14, 785–793. [Google Scholar] [CrossRef]
  17. Oduah, E.I.; Grossman, S.R. Harnessing the vulnerabilities of p53 mutants in lung cancer—Focusing on the proteasome: A new trick for an old foe? Cancer Biol. Ther. 2020, 21, 293–302. [Google Scholar] [CrossRef] [PubMed]
  18. Giacomelli, A.O.; Yang, X.; Lintner, R.E.; McFarland, J.M.; Duby, M.; Kim, J.; Howard, T.P.; Takeda, D.Y.; Ly, S.H.; Kim, E.; et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat. Genet. 2018, 50, 1381–1387. [Google Scholar] [CrossRef]
  19. Labib, M.; Sargent, E.H.; Kelley, S.O. Electrochemical Methods for the Analysis of Clinically Relevant Biomolecules. Chem. Rev. 2016, 116, 9001–9090. [Google Scholar] [CrossRef]
  20. Lin, M.H.; Wen, Y.L.; Li, L.Y.; Pei, H.; Liu, G.; Song, H.Y.; Zuo, X.L.; Fan, C.H.; Huang, Q. Target-Responsive, DNA Nanostructure-Based E-DNA Sensor for microRNA Analysis. Anal. Chem. 2014, 86, 2285–2288. [Google Scholar] [CrossRef]
  21. Guerrero-Esteban, T.; Gutierrez-Sanchez, C.; Garcia-Mendiola, T.; Revenga-Parra, M.; Pariente, F.; Lorenzo, E. Bifunctional carbon nanodots for highly sensitive HER2 determination based on electrochemiluminescence. Sens. Actuators B Chem. 2021, 343, 130096. [Google Scholar] [CrossRef]
  22. Thapa, K.; Liu, W.; Wang, R. Nucleic acid-based electrochemical biosensor: Recent advances in probe immobilization and signal amplification strategies. Wiley Interdiscip. Reviews. Nanomed. Nanobiotechnol. 2022, 14, e1765. [Google Scholar] [CrossRef]
  23. Ferapontova, E.E. DNA Electrochemistry and Electrochemical Sensors for Nucleic Acids. Annu. Rev. Anal. Chem. 2018, 11, 197–218. [Google Scholar] [CrossRef]
  24. Pei, H.; Zuo, X.; Pan, D.; Shi, J.; Huang, Q.; Fan, C. Scaffolded biosensors with designed DNA nanostructures. NPG Asia Mater. 2013, 5, e51. [Google Scholar] [CrossRef]
  25. Yang, F.; Zuo, X.; Fan, C.; Zhang, X.-E. Biomacromolecular nanostructures-based interfacial engineering: From precise assembly to precision biosensing. Natl. Sci. Rev. 2018, 5, 740–755. [Google Scholar] [CrossRef]
  26. Ilkhani, H.; Farhad, S. A novel electrochemical DNA biosensor for Ebola virus detection. Anal. Biochem. 2018, 557, 151–155. [Google Scholar] [CrossRef] [PubMed]
  27. Trotter, M.; Borst, N.; Thewes, R.; von Stetten, F. Review: Electrochemical DNA sensing—Principles, commercial systems, and applications. Biosens. Bioelectron. 2020, 154, 112069. [Google Scholar] [CrossRef]
  28. Farjami, E.; Clima, L.; Gothelf, K.; Ferapontova, E.E. “Off-on” electrochemical hairpin-DNA-based genosensor for cancer diagnostics. Anal. Biochem. 2011, 83, 1594–1602. [Google Scholar] [CrossRef]
  29. Bratu, D.P.; Cha, B.; Mhlanga, M.M.; Kramer, F.R.; Tyagi, S. Visualizing the distribution and transport of mRNAs in living cells. Proc. Natl. Acad. Sci. USA 2003, 100, 13308–13313. [Google Scholar] [CrossRef]
  30. Sadighbayan, D.; Sadighbayan, K.; Khosroushahi, A.Y.; Hasanzadeh, M. Recent advances on the DNA-based electrochemical biosensing of cancer biomarkers: Analytical approach. TrAC Trends Anal. Chem. 2019, 119, 115609. [Google Scholar] [CrossRef]
  31. Zhang, Y.; Hua, R.N.; Zhang, C.Y. Integration of Enzymatic Labeling with Single-Molecule Detection for Sensitive Quantification of Diverse DNA Damages. Anal. Chem. 2020, 92, 4700–4706. [Google Scholar] [CrossRef] [PubMed]
  32. Wu, L.; Lu, X.; Jin, J.; Zhang, H.; Chen, J. Electrochemical DNA biosensor for screening of chlorinated benzene pollutants. Biosens Bioelectron 2011, 26, 4040–4045. [Google Scholar] [CrossRef] [PubMed]
  33. Wu, L.; Lu, X.; Wang, X.; Song, Y.; Chen, J. An electrochemical deoxyribonucleic acid biosensor for rapid genotoxicity screening of chemicals. Anal. Methods 2015, 7, 3347–3352. [Google Scholar] [CrossRef]
  34. Cui, H.-F.; Ye, J.-S.; Zhang, W.-D.; Wang, J.; Sheu, F.-S. Electrocatalytic reduction of oxygen by a platinum nanoparticle/carbon nanotube composite electrode. J. Electroanal. Chem. 2005, 577, 295–302. [Google Scholar] [CrossRef]
  35. Steel, A.B.; Levicky, R.; Herne, T.M.; Tarlov, M.J. Electrochemical quantitation of DNA immobilized on gold. Abstr. Pap. Am. Chem. Soc. 1999, 218, U173. [Google Scholar] [CrossRef] [PubMed]
  36. Lou, X.H.; Zhao, T.; Liu, R.; Ma, J.; Xiao, Y. Self-Assembled DNA Monolayer Buffered Dynamic Ranges of Mercuric Electrochemical Sensor. Anal. Chem. 2013, 85, 7574–7580. [Google Scholar] [CrossRef]
  37. Otero, F.; Shortall, K.; Salaj-Kosla, U.; Tofail, S.A.M.; Magner, E. Electrochemical biosensor for the detection of a sequence of the TP53 gene using a methylene blue labelled DNA probe. Electrochim. Acta 2021, 388, 138642. [Google Scholar] [CrossRef]
  38. Pellitero, M.A.; Shaver, A.; Arroyo-Currás, N. Critical Review—Approaches for the Electrochemical Interrogation of DNA-Based Sensors: A Critical Review. J. Electrochem. Soc. 2019, 167, 037529. [Google Scholar] [CrossRef]
  39. Wan, C.; Qu, A.; Li, M.; Tang, R.; Fu, L.; Liu, X.; Wang, P.; Wu, C. Electrochemical Sensor for Directional Recognition and Measurement of Antibiotic Resistance Genes in Water. Anal. Chem. 2022, 94, 732–739. [Google Scholar] [CrossRef]
  40. Butterworth, A.; Blues, E.; Williamson, P.; Cardona, M.; Gray, L.; Corrigan, D.K. SAM Composition and Electrode Roughness Affect Performance of a DNA Biosensor for Antibiotic Resistance. Biosensors 2019, 9, 22. [Google Scholar] [CrossRef]
  41. Jin, Y.; Yao, X.; Liu, Q.; Li, J. Hairpin DNA probe based electrochemical biosensor using methylene blue as hybridization indicator. Biosens. Bioelectron. 2007, 22, 1126–1130. [Google Scholar] [CrossRef] [PubMed]
  42. Liu, Y.-C.; Zhao, J.; Wu, W.-L.; Yang, Z.-S. Direct electrochemical behavior of cytochrome c on DNA modified glassy carbon electrode and its application to nitric oxide biosensor. Electrochim. Acta 2007, 52, 4848–4852. [Google Scholar] [CrossRef]
  43. Drummond, T.G.; Hill, M.G.; Barton, J.K. Electron transfer rates in DNA films as a function of tether length. J. Am. Chem. Soc. 2004, 126, 15010–15011. [Google Scholar] [CrossRef] [PubMed]
  44. Kekedy-Nagy, L.; Shipovskov, S.; Ferapontova, E.E. Effect of a Dual Charge on the DNA-Conjugated Redox Probe on DNA Sensing by Short Hairpin Beacons Tethered to Gold Electrodes. Anal. Chem. 2016, 88, 7984–7990. [Google Scholar] [CrossRef]
  45. Crossley, L.; Attoye, B.; Vezza, V.; Blair, E.; Corrigan, D.K.; Hannah, S. Establishing a Field-Effect Transistor Sensor for the Detection of Mutations in the Tumour Protein 53 Gene (TP53)—An Electrochemical Optimisation Approach. Biosensors 2019, 9, 141. [Google Scholar] [CrossRef]
  46. Wu, L.; Qu, X. Cancer biomarker detection: Recent achievements and challenges. Chem. Soc. Rev. 2015, 44, 2963–2997. [Google Scholar] [CrossRef]
Figure 1. Schematic diagram of the fabrication and electrochemical response of the ssDNA modified gold electrode.
Figure 1. Schematic diagram of the fabrication and electrochemical response of the ssDNA modified gold electrode.
Biosensors 12 00658 g001
Figure 2. EIS of bare Au electrode (a), ssDNA modified Au electrode (b), MCH modified ssDNA-Au electrode (c), and the biosensor after incubated with cDNA (d).
Figure 2. EIS of bare Au electrode (a), ssDNA modified Au electrode (b), MCH modified ssDNA-Au electrode (c), and the biosensor after incubated with cDNA (d).
Biosensors 12 00658 g002
Figure 3. Cyclic voltammograms of ssDNAAu (A) and dsDNA-Au (B) at different scan rates in pH 7.4 PBS and plot of peak currents vs. square root of scan rates (Inset).
Figure 3. Cyclic voltammograms of ssDNAAu (A) and dsDNA-Au (B) at different scan rates in pH 7.4 PBS and plot of peak currents vs. square root of scan rates (Inset).
Biosensors 12 00658 g003
Figure 4. DPV curves of ssDNA-Au electrode, MCH modified ssDNA-Au electrode, and the biosensor after incubated with 1 μM cDNA.
Figure 4. DPV curves of ssDNA-Au electrode, MCH modified ssDNA-Au electrode, and the biosensor after incubated with 1 μM cDNA.
Biosensors 12 00658 g004
Figure 5. (a) DPV curves of the geno-sensor after 30 min hybridization to cDNA at concentrations of 10 nM, 50 nM, 100 nM, 500 nM, and 1 μM in pH 7.4 PBS. (b) The peak current decrease percentage vs. the logarithm of cDNA concentrations. (c) DPV curves of the electrochemical geno-sensor after 30 min hybridization to 1 μM cDNA, SBM and TBM, respectively. (d) Peak current decrease percentage of the geno-sensor upon exposure to 1 μM cDNA, SBM, and TBM, respectively.
Figure 5. (a) DPV curves of the geno-sensor after 30 min hybridization to cDNA at concentrations of 10 nM, 50 nM, 100 nM, 500 nM, and 1 μM in pH 7.4 PBS. (b) The peak current decrease percentage vs. the logarithm of cDNA concentrations. (c) DPV curves of the electrochemical geno-sensor after 30 min hybridization to 1 μM cDNA, SBM and TBM, respectively. (d) Peak current decrease percentage of the geno-sensor upon exposure to 1 μM cDNA, SBM, and TBM, respectively.
Biosensors 12 00658 g005
Figure 6. DPV response peak currents of five different ssDNA-Au biosensors as a function of scans from 1 to 10 in pH 7.4 PBS before () and following hybridization with 1 μM cDNA ().
Figure 6. DPV response peak currents of five different ssDNA-Au biosensors as a function of scans from 1 to 10 in pH 7.4 PBS before () and following hybridization with 1 μM cDNA ().
Biosensors 12 00658 g006
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Sun, P.; Niu, K.; Du, H.; Li, R.; Chen, J.; Lu, X. Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot. Biosensors 2022, 12, 658. https://doi.org/10.3390/bios12080658

AMA Style

Sun P, Niu K, Du H, Li R, Chen J, Lu X. Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot. Biosensors. 2022; 12(8):658. https://doi.org/10.3390/bios12080658

Chicago/Turabian Style

Sun, Pengcheng, Kai Niu, Haiying Du, Ruixin Li, Jiping Chen, and Xianbo Lu. 2022. "Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot" Biosensors 12, no. 8: 658. https://doi.org/10.3390/bios12080658

APA Style

Sun, P., Niu, K., Du, H., Li, R., Chen, J., & Lu, X. (2022). Sensitive Electrochemical Biosensor for Rapid Screening of Tumor Biomarker TP53 Gene Mutation Hotspot. Biosensors, 12(8), 658. https://doi.org/10.3390/bios12080658

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop